Prestige Wealth Management Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-22
Closed -$807 1175
2022
Q4
$807 Buy
22
+13
+144% +$514 ﹤0.01% 1007
2022
Q3
$0 Buy
9
+4
+80% +$258 ﹤0.01% 1105
2022
Q2
$0 Hold
5
﹤0.01% 1105
2022
Q1
$0 Hold
5
﹤0.01% 1078
2021
Q4
$1K Hold
5
﹤0.01% 983
2021
Q3
$0 Hold
5
﹤0.01% 1069
2021
Q2
$0 Hold
5
﹤0.01% 1055
2021
Q1
$0 Hold
5
﹤0.01% 1059
2020
Q4
$0 Buy
+5
New +$312 ﹤0.01% 1062

Other funds holding SYNH

Prestige Wealth Management Group's SYNH Position: Q1 2023 in Review

Prestige Wealth Management Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 22 shares — an estimated $807 sold.

Prestige Wealth Management Group first reported a position in SYNH in Q4 2020 and held it in 9 quarters. The position peaked at $1K in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Prestige Wealth Management Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 22 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $807.
  • Prestige Wealth Management Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 9 quarters.
  • Prestige Wealth Management Group's Syneos Health, Inc. Class A Common Stock position peaked at $1K in Q4 2021.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Prestige Wealth Management Group's 13F filing for Q1 2023, filed 16 May 2023.